Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
ACTRIMS-ECTRIMS 2014 -- Day 1, afternoon
Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
Long-Term Effects of Exposure to Disease-Modifying Drugs in the Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart Review.
Neuroprotective effects of testosterone treatment in men with multiple sclerosis.
MS Research Roundup: January 31, 2014
IL-17 and Th17 Cells.
Neuroprotection mediated through estrogen receptor-alpha in astrocytes.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.
Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
Episode 22 with Dr. Paul Matthews discussing the Optimize project in the UK
Blood Brain Barrier Meeting
Nancy Davis Foundation Annual MS Expo and Health Forum
Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for RRMS
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.
Use of fumaric acid esters in psoriasis.
The relevance of animal models in multiple sclerosis research.
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Gender and the hygiene hypothesis.
Episode 56 with Dr. Gavin Giovannoni, on early phase 3 results of ocrelizumab, the first experimental drug to show some benefit in a progressive form of multiple sclerosis in a major trial
FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
28th Congress of European Committee for Treatment and Research in Multiple Sclerosis Congress

Pages